NATHBIOGENNath Bio-Genes

₹173.74+0.93%

Market Cap

₹328.77 Cr

Stock P/E

7.73

ROCE

6.89%

ROE

6.15%

Book Value

₹357.61

Financials

YoY Net Sales

EPS Growth

Operating Margin

You might have missed

No Recent News

No recent news available for this stock.

Shareholding

Holdings

Distribution

Promoter

Foreign Investors

Domestic Investors

Public

From Last Concall

POSITIVES

NEGATIVES

Peers Summary

Sector Leader

Nath Bio-Genes (India) Ltd. shows potential as a value pick with attractive valuation metrics but has mixed growth and profitability compared to its peers. Companies like Kaveri Seed Company Ltd. and Bombay Burmah Trading Corporation Ltd. stand out as strong performers with better profitability and growth metrics. While Nath Bio-Genes is undervalued, it faces stiff competition from more profitable peers in the agriculture sector.

Key Points

• Nath Bio-Genes has low PE and PBV ratios, indicating potential undervaluation.
• Kaveri Seed Company Ltd. leads in profitability with an ROE of 20.67% and strong growth metrics.
• Bombay Burmah Trading Corporation Ltd. is a strong performer due to high ROE and EPS over the last three years.

Top Performers

Kaveri Seed Company Ltd.

Highest profitability metrics with strong growth in revenue and EPS.

Bombay Burmah Trading Corporation Ltd.

Strong ROE and consistent revenue growth, albeit at a high valuation.

Explore

Watchlists

Command Palette